Authors: Talvensaari-Mattila, A Paakko, P Blanco-Sequeiros, G Turpeenniemi-Hujanen, T

Citation: A. Talvensaari-mattila et al., Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy, BREAST CANC, 65(1), 2001, pp. 55-61

Authors: Talvensaari-Mattila, A Paakko, P Turpeenniemi-Hujanen, T

Citation: A. Talvensaari-mattila et al., MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma, BREAST CANC, 58(3), 1999, pp. 287-293

Authors: Talvensaari-Mattila, A Apaja-Sarkkinen, M Hoyhtya, M Westerlund, A Puistola, U Turpeenniemi-Hujanen, T

Citation: A. Talvensaari-mattila et al., Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation, GYNECOL ONC, 72(3), 1999, pp. 306-311